WO2014030142A3 - Nitroimidazole compounds and their use in cancer therapy - Google Patents
Nitroimidazole compounds and their use in cancer therapy Download PDFInfo
- Publication number
- WO2014030142A3 WO2014030142A3 PCT/IB2013/056824 IB2013056824W WO2014030142A3 WO 2014030142 A3 WO2014030142 A3 WO 2014030142A3 IB 2013056824 W IB2013056824 W IB 2013056824W WO 2014030142 A3 WO2014030142 A3 WO 2014030142A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- cancer therapy
- nitroimidazole compounds
- compound
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof, formula (I) wherein m, n, X, Y and Z are as defined herein. Also provided are pharmaceutical compositions containing compounds of Formula (I), and methods of treating cancer and/or improving the response of tumors to radiotherapy by administering a compound of Formula (I) to a warm-blooded animal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ602023 | 2012-08-24 | ||
NZ60202312 | 2012-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014030142A2 WO2014030142A2 (en) | 2014-02-27 |
WO2014030142A3 true WO2014030142A3 (en) | 2014-04-17 |
Family
ID=50150445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2013/056824 WO2014030142A2 (en) | 2012-08-24 | 2013-08-23 | Nitroimidazole compounds and their use in cancer therapy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014030142A2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1215858A (en) * | 1968-05-03 | 1970-12-16 | Merck & Co Inc | Nitroimidazole derivatives |
US3629431A (en) * | 1969-06-16 | 1971-12-21 | Pfizer | Use of 1-alkylsulfonylalkyl-2-alkyl-5 - nitroimidazoles in controlling coccidiosis |
AU3432971A (en) * | 1970-10-08 | 1973-04-12 | CARLO ERBA Sp. A | Substituted 2,2-biimidazoles and process for their preperation |
GB1399291A (en) * | 1971-09-02 | 1975-07-02 | Merck & Co Inc | 5-cyano-4-nitroimidazoles and their preparation |
DE2515110A1 (en) * | 1974-04-19 | 1975-10-23 | Crc Ricerca Chim | PROCESS FOR THE PREPARATION OF 5-NITROIMIDAZOLE DERIVATIVES |
CN1634041A (en) * | 2004-10-29 | 2005-07-06 | 文斌 | Use of anti-infective drug in treating cancer |
-
2013
- 2013-08-23 WO PCT/IB2013/056824 patent/WO2014030142A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1215858A (en) * | 1968-05-03 | 1970-12-16 | Merck & Co Inc | Nitroimidazole derivatives |
US3629431A (en) * | 1969-06-16 | 1971-12-21 | Pfizer | Use of 1-alkylsulfonylalkyl-2-alkyl-5 - nitroimidazoles in controlling coccidiosis |
AU3432971A (en) * | 1970-10-08 | 1973-04-12 | CARLO ERBA Sp. A | Substituted 2,2-biimidazoles and process for their preperation |
GB1399291A (en) * | 1971-09-02 | 1975-07-02 | Merck & Co Inc | 5-cyano-4-nitroimidazoles and their preparation |
DE2515110A1 (en) * | 1974-04-19 | 1975-10-23 | Crc Ricerca Chim | PROCESS FOR THE PREPARATION OF 5-NITROIMIDAZOLE DERIVATIVES |
CN1634041A (en) * | 2004-10-29 | 2005-07-06 | 文斌 | Use of anti-infective drug in treating cancer |
Non-Patent Citations (14)
Title |
---|
BHUJANGA RAO, A. K. S. ET AL.: "Novel Synthesis of 4(5)-Cyclic Amino-5(4)- Nitroimidazoles", SYNTHETIC COMMUNICATIONS, vol. 24, no. 3, 1994, pages 341 - 351 * |
BHUJANGA RAO, A. K. S. ET AL.: "Regioselective Alkylation of 4(5)-Nitro-1H-Imidazoles in Acetic Media: Study of Temperature Effects", J. CHEM. SOC. PERKINS TRANS., vol. 1, no. 17, 1994, pages 2399 - 2402 * |
CHEMICAL ABSTRACTS, 16 November 1984, Columbus, Ohio, US; abstract no. 28795-25-7 * |
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 52455-84-2 * |
DESAI, D. G. ET AL.: "Synthesis and Antibacterial Activity of Nickel Complex of some Novel Nitroimidazole", PHARMA SCIENCE MONITOR, vol. 3, no. 2, April 2012 (2012-04-01), pages 133 - 141 * |
HAY, M. P. ET AL.: "Hypoxia-Selective Antitumor Agents. 10. Bis nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility", J. MED. CHEM., vol. 38, 1996, pages 1928 - 1941 * |
LONG, W. ET AL.: "Quantitative Structure Activity Relationship Modeling for Predicting Radiosensitization Effectiveness of Nitroimidazole Compounds", J. RADIAT. RES., vol. 51, 2010, pages 563 - 572 * |
MARTIN BROWN, J. ET AL.: "Partition Coefficient as a Guide to the Development of Radiosensitizers which are Less Toxic than Misonidazole", RADIATION RESEARCH, vol. 82, no. 1, 1980, pages 171 - 190 * |
RAMALHO, T. C. ET AL.: "Theoretical evaluation of adiabatic and vertical electron affinity of some radiosensitizers in solution using FEP, ab initio and DFT methods", BIOPHYSICAL CHEMISTRY, vol. 110, 2004, pages 267 - 279 * |
SALAHUDDIN, A. ET AL.: "Metronidazole thiosalicylate conjugates: Synthesis, crystal structure, docking studies and antiamoebic activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, July 2012 (2012-07-01), pages 5694 - 5699 * |
SCOTT, P. W. ET AL.: "A Novel Metabolite of Tinidazole involving Nitro-group migration", BIOCHEMICAL PHARMACOLOGY, vol. 34, no. 3, 1985, pages 451 - 458 * |
SHANKER, S. ET AL.: "Sensitivity of Gardnerella Vaginalis to Metabolites of Metronidazole and Tinidazole", THE LANCET, 1982, pages 167 * |
STRATFORD, M. R. L. ET AL.: "Radiosensitizer-DNA Interactions in Relation to Intracellular Uptake", INT. J. RADIATION ONCOLOGY BID PHYS.., vol. 16, 1989, pages 1007 - 1010 * |
WINKELMANN, E. ET AL.: "Chemotherapeutically Active Nitro Compounds", ARZNEIM.- FORSCH., vol. 27, no. 12, 1977, pages 2251 - 2263 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014030142A2 (en) | 2014-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SA515360469B1 (en) | Heterocyclic compounds for inhibiting glutaminase and their methods of use | |
MX345928B (en) | Therapeutically active compositions and their methods of use. | |
EP4335511A3 (en) | Small molecule trail gene induction by normal and tumor cells as an anticancer therapy | |
WO2012118812A3 (en) | Substituted 6,5-fused bicyclic heteroaryl compounds | |
PH12013502565A1 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
EA201600204A1 (en) | HINAZOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR APPLICATION FOR THE PREVENTION OR TREATMENT OF THE TUMOR | |
MX362550B (en) | Heterocyclic inhibitors of glutaminase. | |
MX343706B (en) | Novel heterocyclic derivatives. | |
MX2014009757A (en) | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy. | |
UA109010C2 (en) | Morpholino pyrividines and their use in therapy | |
UA109464C2 (en) | Spiro-oxindoles as mdm2 antagonists | |
NZ603155A (en) | Phospholipid drug analogs | |
WO2012141796A3 (en) | Prostate cancer therapy with hsp90 inhibitory compounds | |
UA113541C2 (en) | Substituted pyrrolidine-2-carboxamides | |
BR112012027743A2 (en) | cyclopropyl dicarboxamides and analogs exhibiting anticancer and antiproliferative activities | |
WO2012139039A3 (en) | Bisphenol compounds and methods for their use | |
MX2013010898A (en) | Novel pyrimidine derivatives. | |
MX2013012588A (en) | Kinase inhibitors. | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
PH12015501088A1 (en) | Dimeric compounds | |
PH12015500376A1 (en) | Novel bicyclic pyridinones | |
MX2012013274A (en) | Novel pyrimidine derivatives. | |
TN2015000574A1 (en) | Compounds and compositions as inhibitors of mek | |
WO2013040227A3 (en) | Therapeutic compounds | |
NZ723971A (en) | Methods and compositions for treating ewings sarcoma family of tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13831598 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13831598 Country of ref document: EP Kind code of ref document: A2 |